Lv7
4010 积分 2020-11-25 加入
Effects of mineralocorticoid receptor antagonists on left ventricular mass in chronic kidney disease patients: a systematic review and meta-analysis
3天前
已完结
Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)
3天前
已完结
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
3天前
已完结
Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy
3天前
已完结
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
3天前
已完结
The Selective Endothelin Receptor Antagonist SC0062 in IgA Nephropathy
1个月前
已完结
Efficacy and Safety of Ravulizumab in IgA Nephropathy
1个月前
已完结
Old known and possible new biomarkers of ANCA-associated vasculitis
1个月前
已完结
Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy
2个月前
已完结
The complement system in IgAN: mechanistic context for therapeutic opportunities
2个月前
已完结
皖公网安备34019202002308
